ArticleNeuro-oncology2017

Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.

Matthias Holdhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.